FDA’s TV Ad Review Is Unconstitutional, PhRMA Says, Or Maybe Should Be A Reg
Executive Summary
A draft guidance that outlines six categories of drug ads FDA wants submitted for prior review is a violation of advertisers’ free speech rights, the industry group argues. Other comments float a storyboard compromise.
You may also be interested in...
Drug Sample Reporting Must Be Streamlined, PhRMA Tells FDA
FDA could be flooded with “millions of duplicative signatures” every time a health care practitioner requests a drug sample, the trade group warns.
Biosimilars’ Next Big Hurdle For FDA Could Be Clinician Education
Companies and other groups want clear FDA communication on biosimilars as pharmacists look for an Orange Book-like reference manual to be ready for prescriptions.
DTC Pre-review Requirement Broadly Defined Under FDA Draft Guidance
The agency’s draft guidance on prereview of television advertisements also requires companies to submit the information they rely on to support claims in an ad.